Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: Master's Award: Canada Graduate Scholarships

University of Alberta

$27,000.00

Influence of Fatty Acid-Binding Protein 7 on Glioblastoma Metabolism

EF 2024-25

Résumé
Glioblastoma (GBM) is an aggressive brain cancer with a dismal prognosis. Due to the infiltrative nature of the tumour, conventional treatment using surgery, radiation therapy and chemotherapy invariably fails, and the cancer often recurs within 6 months after surgery. Resistance to treatment and tumour recurrence have been attributed to stem-like cells, a subtype of cancer cells found in the most infiltrative parts of GBM tumours. Stem-like cells highly express FABP7, a protein that facilitates the uptake and transport of lipids (or fats) in the cells, especially DHA (an omega-3) and AA (an omega-6). Interestingly, DHA is associated with properties that prevent tumour growth, whereas AA promotes tumour growth. Metabolism refers to how molecules, such as sugars and lipids, are broken down in cells to produce energy, which is a process that occurs in the cells mitochondria. Stem-like cells extensively reprogram their metabolism; instead of using sugars, they rely on lipids to produce energy. Because FABP7 has been found to interact with mitochondria, we propose that: (1) FABP7 plays a role in GBM metabolic reprogramming and (2) some of DHA anti-tumor properties involve mitochondrial dysfunction. We aim to expand our understanding of the metabolic pathways preferred by glioblastoma stem-like cells and investigate how FABP7 mediates mitochondrial function in the presence of DHA or AA. Studying these metabolic features may hold the key to targeting cancer-specific pathways, especially if the anti-tumor properties of DHA can be turned against stem-like cells. Targeting the populations of stem-like cells in GBM could become an effective therapeutic strategy to prevent the infiltration of GBM tumours into brain tissue, thereby improving treatment and patient prognosis.
Programme
Master's Award: Canada Graduate Scholarships
Bénéficiaire
Emplacement
Alberta, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
530093
Name
Bernier Cécilia
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Influence of Fatty Acid-Binding Protein 7 on Glioblastoma Metabolism
Programtype2
Studentship Programs
Orgnameinp2
University of Alberta
Cihramount2
$27,000
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Arachidonic Acid; Docosahexaenoic Acid; Fatty Acid Oxidation; Fatty Acid-Binding Protein 7; Glioblastoma; Glycolysis; Lipid Droplets; Metabolism; Mitochondria; Tumour Microenvironment
Abstract
Glioblastoma (GBM) is an aggressive brain cancer with a dismal prognosis. Due to the infiltrative nature of the tumour, conventional treatment using surgery, radiation therapy and chemotherapy invariably fails, and the cancer often recurs within 6 months after surgery. Resistance to treatment and tumour recurrence have been attributed to stem-like cells, a subtype of cancer cells found in the most infiltrative parts of GBM tumours. Stem-like cells highly express FABP7, a protein that facilitates the uptake and transport of lipids (or fats) in the cells, especially DHA (an omega-3) and AA (an omega-6). Interestingly, DHA is associated with properties that prevent tumour growth, whereas AA promotes tumour growth. Metabolism refers to how molecules, such as sugars and lipids, are broken down in cells to produce energy, which is a process that occurs in the cells mitochondria. Stem-like cells extensively reprogram their metabolism; instead of using sugars, they rely on lipids to produce energy. Because FABP7 has been found to interact with mitochondria, we propose that: (1) FABP7 plays a role in GBM metabolic reprogramming and (2) some of DHA anti-tumor properties involve mitochondrial dysfunction. We aim to expand our understanding of the metabolic pathways preferred by glioblastoma stem-like cells and investigate how FABP7 mediates mitochondrial function in the presence of DHA or AA. Studying these metabolic features may hold the key to targeting cancer-specific pathways, especially if the anti-tumor properties of DHA can be turned against stem-like cells. Targeting the populations of stem-like cells in GBM could become an effective therapeutic strategy to prevent the infiltration of GBM tumours into brain tissue, thereby improving treatment and patient prognosis.
Competitiondate
202412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Bernier, Cécilia
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $27,000~ $0~